Please login to the form below

Not currently logged in

Creston Unlimited

This page shows the latest Creston Unlimited news and features for those working in and with pharma, biotech and healthcare.

Health Unlimited forms partnership with HealthUnlocked

Health Unlimited forms partnership with HealthUnlocked

Health Unlimited, which is part of the Creston Unlimited group, said the partnership would also create referral opportunities for HealthUnlocked across other areas of its parent company's operations. ... And it noted that the London-based social network

Latest news

  • Creston acquires How Splendid Creston acquires How Splendid

    Following the acquisition, Splendid will also be re-branded as 'Splendid Unlimited', in-line with Creston Unlimited's branding and corporate philosophy. ... Barrie Brien, group chief executive of Creston, said: “Splendid is an excellent business which

  • Creston Health rebrands under Health Unlimited banner Creston Health rebrands under Health Unlimited banner

    Creston Health has rebranded as Health Unlimited in a move that will see the UK-based marketing communication group's agencies work more closely together.  . ... Health Unlimited's CEO Catherine Warne said: “We are a group of agencies who can work

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Liberation names account manager Liberation names account manager

    Promotion for Danielle Guildford-Sharp. Liberation Unlimited has promoted Danielle Guildford-Sharp to an account manager role. ... of Liberation Unlimited, which recently changed its name from Liberations Communications as part of a rebrand of its parent

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company

Conversis is a translation company specialising in translation and localisation for the Life Science and Pharmaceutical industry, with particular focus...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...